Literature DB >> 30763825

Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.

Wouter P Te Rijdt1, Angeliki Asimaki2, Jan D H Jongbloed3, Edgar T Hoorntje3, Elisabetta Lazzarini4, Paul A van der Zwaag3, Rudolf A de Boer5, J Peter van Tintelen6, Jeffrey E Saffitz7, Maarten P van den Berg5, Albert J H Suurmeijer8.   

Abstract

Phospholamban (PLN) p.Arg14del cardiomyopathy is characterized by a distinct arrhythmogenic biventricular phenotype that can be predominantly left ventricular, right ventricular, or both. Our aim was to further elucidate distinct features of this cardiomyopathy with respect to the distribution of desmosomal proteins observed by immunofluorescence (IF) in comparison to desmosomal arrhythmogenic cardiomyopathy and co-existent genetic variants. We studied eight explanted heart specimens from PLN p.Arg14del mutation carriers. Macro- and microscopic examination revealed biventricular presence of fibrofatty replacement and interstitial fibrosis. Five out of 8 (63%) patients met consensus criteria for both arrhythmogenic right ventricular cardiomyopathy (ARVC) and dilated cardiomyopathy (DCM). In four cases, targeted next-generation sequencing revealed one additional pathogenic variant and six variants of unknown significance. IF showed diminished junction plakoglobin signal intensity at the intercalated disks in 4 (67%) out of 6 cases fulfilling ARVC criteria but normal intensity in both cases fulfilling only DCM criteria. Notably, the four cases with diminished junction plakoglobin were also those where an additional gene variant was detected. IF for two proteins recently investigated in desmosomal arrhythmogenic cardiomyopathy (ACM), synapse-associated protein 97 and glycogen synthase kinase-3 beta, showed a distinct distributional pattern in comparison to desmosomal ACM. In 7 (88%) out of 8 cases we observed both a strong synapse-associated protein 97 signal at the sarcomeres and no glycogen synthase kinase-3 beta translocation to the intercalated discs. Phospholamban p.Arg14del cardiomyopathy is characterized by a distinct molecular signature compared to desmosomal ACM, specifically a different desmosomal protein distribution. This study substantiates the idea that additional genetic variants play a role in the phenotypical heterogeneity.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmogenic cardiomyopathy; Dilated cardiomyopathy; Immunofluorescence; Next-generation sequencing; Phospholamban

Mesh:

Substances:

Year:  2018        PMID: 30763825     DOI: 10.1016/j.carpath.2018.12.006

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  6 in total

Review 1.  Calcium as a Key Player in Arrhythmogenic Cardiomyopathy: Adhesion Disorder or Intracellular Alteration?

Authors:  Francesco Moccia; Francesco Lodola; Ilaria Stadiotti; Chiara Assunta Pilato; Milena Bellin; Stefano Carugo; Giulio Pompilio; Elena Sommariva; Angela Serena Maione
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

2.  AKAP6 and phospholamban colocalize and interact in HEK-293T cells and primary murine cardiomyocytes.

Authors:  Farigol Hakem Zadeh; Allen C T Teng; Uros Kuzmanov; Paige J Chambers; Allan R Tupling; Anthony O Gramolini
Journal:  Physiol Rep       Date:  2019-07

3.  Buccal Mucosa Cells as a Potential Diagnostic Tool to Study Onset and Progression of Arrhythmogenic Cardiomyopathy.

Authors:  Helen E Driessen; Stephanie M van der Voorn; Mimount Bourfiss; Freyja H M van Lint; Ferogh Mirzad; Laila El Onsri; Marc A Vos; Toon A B van Veen
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

4.  Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation.

Authors:  Siyu Guo; Yingying Tan; Zhihong Huang; Yikui Li; Weiyu Liu; Xiaotian Fan; Jingyuan Zhang; Antony Stalin; Changgeng Fu; Zhishan Wu; Penglong Wang; Wei Zhou; Xinkui Liu; Chao Wu; Shanshan Jia; Jinyan Zhang; Xiaoxia Duan; Jiarui Wu
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

5.  Prognostic model of patients with liver cancer based on tumor stem cell content and immune process.

Authors:  Weikaixin Kong; Miaomiao Gao; Yuchen Jin; Weiran Huang; Zhuo Huang; Zhengwei Xie
Journal:  Aging (Albany NY)       Date:  2020-08-27       Impact factor: 5.682

Review 6.  Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy.

Authors:  Carlos Bueno-Beti; Angeliki Asimaki
Journal:  Front Cardiovasc Med       Date:  2021-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.